Results 171 to 180 of about 7,537 (182)

Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers

British Journal of Anaesthesia, 2008
exaly  

Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial

British Journal of Anaesthesia, 2018
exaly  

Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers

British Journal of Anaesthesia, 2018
exaly  

Three cases of suspected sugammadex-induced hypersensitivity reactions

British Journal of Anaesthesia, 2012
exaly  

Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine

British Journal of Anaesthesia, 2008
exaly  

Unrestricted Access to Sugammadex: Impact on Neuromuscular Blocking Agent Choice, Reversal Practice and Associated Healthcare Costs

Anaesthesia and Intensive Care, 2012
exaly  

Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg−1 for reversal of deep neuromuscular blockade in patients with severe renal impairment

British Journal of Anaesthesia, 2015
exaly  

Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20) ,

British Journal of Anaesthesia, 2016
exaly  

Sugammadex is cleared rapidly and primarily unchanged via renal excretion

Biopharmaceutics and Drug Disposition, 2011
exaly  

Sugammadex hypersensitivity: a multicentre retrospective analysis of a large Australian cohort

British Journal of Anaesthesia
Danielle Crimmins, Christian Van Nieuwenhuysen, Syeda F Zahir   +2 more
exaly